Matches in SemOpenAlex for { <https://semopenalex.org/work/W1880892126> ?p ?o ?g. }
- W1880892126 endingPage "9" @default.
- W1880892126 startingPage "1" @default.
- W1880892126 abstract "The clinical utility of minimal residual disease (MRD) analysis in acute myeloid leukaemia (AML) is not yet defined. We analysed the prognostic impact of MRD level at complete remision after induction therapy using multiparameter flow cytometry in 306 non-APL AML patients. First, we validated the prognostic value of MRD-thresholds we have previously proposed (≥0.1%; ≥0.01–0.1%; and <0.01), with a 5-year RFS of 38%, 50% and 71%, respectively (p = 0.002). Cytogenetics is the most relevant prognosis factor in AML, however intermediate risk cytogenetics represent a grey zone that require other biomarkers for risk stratification, and we show that MRD evaluation discriminate three prognostic subgroups (p = 0.03). Also, MRD assessments yielded relevant information on favourable and adverse cytogenetics, since patients with favourable cytogenetics and high MRD levels have poor prognosis and patients with adverse cytogenetics but undetectable MRD overcomes the adverse prognosis. Interestingly, in patients with intermediate or high MRD levels, intensification with transplant improved the outcome as compared with chemotherapy, while the type of intensification therapy did not influenced the outcome of patients with low MRD levels. Multivariate analysis revealed age, MRD and cytogenetics as independent variables. Moreover, a scoring system, easy in clinical practice, was generated based on MRD level and cytogenetics." @default.
- W1880892126 created "2016-06-24" @default.
- W1880892126 creator A5003682435 @default.
- W1880892126 creator A5006378658 @default.
- W1880892126 creator A5006531102 @default.
- W1880892126 creator A5007435954 @default.
- W1880892126 creator A5014009900 @default.
- W1880892126 creator A5015643634 @default.
- W1880892126 creator A5018662284 @default.
- W1880892126 creator A5020702876 @default.
- W1880892126 creator A5020989412 @default.
- W1880892126 creator A5021825370 @default.
- W1880892126 creator A5023429308 @default.
- W1880892126 creator A5033127381 @default.
- W1880892126 creator A5033254447 @default.
- W1880892126 creator A5051332028 @default.
- W1880892126 creator A5057189669 @default.
- W1880892126 creator A5059635260 @default.
- W1880892126 creator A5059946306 @default.
- W1880892126 creator A5065570607 @default.
- W1880892126 creator A5069753479 @default.
- W1880892126 creator A5070525832 @default.
- W1880892126 creator A5071831990 @default.
- W1880892126 creator A5075481352 @default.
- W1880892126 creator A5076578888 @default.
- W1880892126 creator A5088409474 @default.
- W1880892126 date "2016-01-01" @default.
- W1880892126 modified "2023-10-17" @default.
- W1880892126 title "Minimal residual disease evaluation by flow cytometry is a complementary tool to cytogenetics for treatment decisions in acute myeloid leukaemia" @default.
- W1880892126 cites W1534965621 @default.
- W1880892126 cites W1919339218 @default.
- W1880892126 cites W1970711964 @default.
- W1880892126 cites W1981110731 @default.
- W1880892126 cites W1984938965 @default.
- W1880892126 cites W1986342021 @default.
- W1880892126 cites W1992453745 @default.
- W1880892126 cites W1992656466 @default.
- W1880892126 cites W1994631062 @default.
- W1880892126 cites W1995349492 @default.
- W1880892126 cites W2005410572 @default.
- W1880892126 cites W2020417052 @default.
- W1880892126 cites W2033560619 @default.
- W1880892126 cites W2038242472 @default.
- W1880892126 cites W2041569392 @default.
- W1880892126 cites W2042814209 @default.
- W1880892126 cites W2043038685 @default.
- W1880892126 cites W2068208386 @default.
- W1880892126 cites W2071206691 @default.
- W1880892126 cites W2075139424 @default.
- W1880892126 cites W2078041280 @default.
- W1880892126 cites W2083006206 @default.
- W1880892126 cites W2087296000 @default.
- W1880892126 cites W2090630520 @default.
- W1880892126 cites W2105608321 @default.
- W1880892126 cites W2107810465 @default.
- W1880892126 cites W2118250079 @default.
- W1880892126 cites W2120204058 @default.
- W1880892126 cites W2124159210 @default.
- W1880892126 cites W2128541003 @default.
- W1880892126 cites W2130770490 @default.
- W1880892126 cites W2133262115 @default.
- W1880892126 cites W2138265677 @default.
- W1880892126 cites W2147572934 @default.
- W1880892126 cites W2148047805 @default.
- W1880892126 cites W2153382436 @default.
- W1880892126 cites W2159875685 @default.
- W1880892126 cites W2162411731 @default.
- W1880892126 cites W2163358530 @default.
- W1880892126 cites W3149097951 @default.
- W1880892126 cites W90219691 @default.
- W1880892126 doi "https://doi.org/10.1016/j.leukres.2015.10.002" @default.
- W1880892126 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/26598032" @default.
- W1880892126 hasPublicationYear "2016" @default.
- W1880892126 type Work @default.
- W1880892126 sameAs 1880892126 @default.
- W1880892126 citedByCount "27" @default.
- W1880892126 countsByYear W18808921262016 @default.
- W1880892126 countsByYear W18808921262017 @default.
- W1880892126 countsByYear W18808921262018 @default.
- W1880892126 countsByYear W18808921262019 @default.
- W1880892126 countsByYear W18808921262020 @default.
- W1880892126 countsByYear W18808921262021 @default.
- W1880892126 countsByYear W18808921262022 @default.
- W1880892126 countsByYear W18808921262023 @default.
- W1880892126 crossrefType "journal-article" @default.
- W1880892126 hasAuthorship W1880892126A5003682435 @default.
- W1880892126 hasAuthorship W1880892126A5006378658 @default.
- W1880892126 hasAuthorship W1880892126A5006531102 @default.
- W1880892126 hasAuthorship W1880892126A5007435954 @default.
- W1880892126 hasAuthorship W1880892126A5014009900 @default.
- W1880892126 hasAuthorship W1880892126A5015643634 @default.
- W1880892126 hasAuthorship W1880892126A5018662284 @default.
- W1880892126 hasAuthorship W1880892126A5020702876 @default.
- W1880892126 hasAuthorship W1880892126A5020989412 @default.
- W1880892126 hasAuthorship W1880892126A5021825370 @default.
- W1880892126 hasAuthorship W1880892126A5023429308 @default.
- W1880892126 hasAuthorship W1880892126A5033127381 @default.
- W1880892126 hasAuthorship W1880892126A5033254447 @default.